Pharmacological inhibition of Piezo1, TRPV4 and phospholipase A2 as well as knock out of both channels in mice have shown a protection against AP hallmarks suggesting these novel molecular targets could be highly important in future pressure-induced AP treatment. The gene discussed is PIEZO1; the disease is alkaline phosphatase measurement.